| Product Code: ETC6188153 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Softgel capsules are gaining popularity in the Australia pharmaceutical market due to their ease of swallowing, improved bioavailability, and ability to encapsulate both liquid and semi-solid formulations. Pharmaceutical and nutraceutical companies are increasingly using softgel technologies for over-the-counter drugs, dietary supplements, and specialized therapies.
Softgel capsules are witnessing growing demand in Australia owing to their ease of consumption, better bioavailability, and suitability for fat-soluble formulations. The trend also reflects consumer preference for over-the-counter vitamins and supplements in softgel form. Manufacturers are exploring plant-based gelatin alternatives to cater to the vegan and vegetarian population segments.
The production of pharmaceutical softgel capsules in Australia is challenged by formulation difficulties, particularly when dealing with moisture-sensitive or heat-labile drugs. Regulatory compliance for gelatin sourcing and halal/kosher certifications can also create obstacles. Furthermore, limited local manufacturing capacities often necessitate dependence on imports, affecting cost efficiency and supply chain reliability.
The Australia government supports investment in nutraceutical and pharmaceutical capsule production through the Manufacturing Modernisation Fund and local pharmaceutical grants. Import tariffs are low on raw materials, and TGA registration processes for softgel drugs and supplements ensure investor confidence in compliant market entry.
The production and regulation of softgel capsules in Australia are governed under the Therapeutic Goods Regulations 1990, requiring compliance with GMP and product listing on the Australia Register of Therapeutic Goods (ARTG). Government policies ensure stringent oversight of excipients and gelatin sources to address concerns around allergens, religious dietary requirements, and BSE risk. Additionally, the government has supported initiatives to localize capsule production amid global supply chain disruptions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Softgel Capsules Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Softgel Capsules Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Softgel Capsules Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Pharmaceutical Softgel Capsules Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Australia leading to higher demand for pharmaceutical products. |
4.2.2 Growing awareness about the benefits of softgel capsules such as ease of consumption and faster absorption. |
4.2.3 Technological advancements in softgel manufacturing processes leading to improved quality and customization options. |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the pharmaceutical industry impacting the production and distribution of softgel capsules. |
4.3.2 Pricing pressures and cost constraints affecting the profitability of softgel capsule manufacturers. |
5 Australia Pharmaceutical Softgel Capsules Market Trends |
6 Australia Pharmaceutical Softgel Capsules Market, By Types |
6.1 Australia Pharmaceutical Softgel Capsules Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Overview, 2021- 2031F |
6.1.4 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.5 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.6 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Others (Pharma. Grade Supplements), 2021- 2031F |
6.2 Australia Pharmaceutical Softgel Capsules Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Overview, 2021- 2031F |
6.2.3 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Application 1, 2021- 2031F |
6.2.4 Australia Pharmaceutical Softgel Capsules Market Revenues & Volume, By Application 2, 2021- 2031F |
7 Australia Pharmaceutical Softgel Capsules Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Softgel Capsules Market Export to Major Countries |
7.2 Australia Pharmaceutical Softgel Capsules Market Imports from Major Countries |
8 Australia Pharmaceutical Softgel Capsules Market Key Performance Indicators |
8.1 Research and development investment in innovative formulations and technologies for softgel capsules. |
8.2 Adoption rate of softgel capsules by healthcare professionals and patients. |
8.3 Number of new product launches and market approvals for softgel capsules in Australia. |
9 Australia Pharmaceutical Softgel Capsules Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Softgel Capsules Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Pharmaceutical Softgel Capsules Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Pharmaceutical Softgel Capsules Market - Competitive Landscape |
10.1 Australia Pharmaceutical Softgel Capsules Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Softgel Capsules Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here